Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R9PS
|
|||
| Former ID |
DIB002617
|
|||
| Drug Name |
Aviscumine
|
|||
| Synonyms |
RML; RViscumin; Recombinant mistletoe lectin; CY-503; Recombinant protein (cancer), Cytavis BioPharma
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Company |
BRAIN Biotechnology Research and Information Network GmbH
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00932724) CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.